A-111 Sub-analysis of the BELIEVE STUDY: Effectiveness and safety for retreatment with Brentuximab-vedotin in relapsed/refractory (R/R) Cutaneous T Cell Lymphoma (CTCL): a retrospective medical chart review study in Spain. NCT:04998331 | Publicación